BackPT Kalbe Farma Tbk Overview

PT Kalbe Farma Tbk Total Current Liabilities

Latest total current liabilities for PTKFF: $5.6T.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$5612.81B
23.78% YoYΔ $1078.29B vs prior year quarter

Peer average

Loading

PT Kalbe Farma Tbk Total Current Liabilities History

Loading

PT Kalbe Farma Tbk vs. peers: Total Current Liabilities Comparison

Loading

PT Kalbe Farma Tbk Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PT Kalbe Farma Tbk (PTKFF) FAQ

The latest total current liabilities for PTKFF is $5.6T as of March 2026. That compares with $4.5T in the prior-year period — up 23.8% year over year. Investors often review this figure alongside PT Kalbe Farma Tbk's historical trend and sector peers before judging valuation or financial health.

Over the past year, PTKFF's total current liabilities moved from $4.5T to $5.6T — a 23.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PT Kalbe Farma Tbk's operating scale or balance-sheet position.

A total current liabilities figure of $5.6T for PTKFF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PTKFF's total current liabilities ($5.6T), review year-over-year change from $4.5T, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack PT Kalbe Farma Tbk's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.